Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 1997;272:22642–7.

Article  PubMed  CAS  Google Scholar 

Liu Q, Palmgren VAC, Danen EH, Le Dévédec SE. Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research. Mol Biol Rep. 2022;49:10961–73.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Keith B, Johnson RS, Simon MC. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2011;12:9–22.

Article  PubMed  PubMed Central  Google Scholar 

Yang SL, Wu C, Xiong ZF, Fang X. Progress on hypoxia-inducible factor-3: Its structure, gene regulation and biological function (Review). Mol Med Rep. 2015;12:2411–6.

Article  PubMed  CAS  Google Scholar 

Pan J, Zhang L, Li D, Li Y, Lu M, Hu Y, et al. Hypoxia-inducible factor-1: regulatory mechanisms and drug therapy in myocardial infarction. Eur J Pharmacol. 2024;963: 176277.

Article  PubMed  CAS  Google Scholar 

Albadari N, Deng S, Li W. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy. Expert Opin Drug Discov. 2019;14:667–82.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Paredes F, Williams HC, San MA. Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021;502:133–42.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shen C, Beroukhim R, Schumacher SE, Zhou J, Chang M, Signoretti S, Kaelin WG Jr. Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene. Cancer Discov. 2011;1:222–35.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Krieg M, Haas R, Brauch H, Acker T, Flamme I. Plate KH Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene. 2000;19:5435–43.

Article  PubMed  CAS  Google Scholar 

Taylor CT, McElwain JC. Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans. Physiology (Bethesda). 2010;25:272–9.

PubMed  CAS  Google Scholar 

Mills DB, Francis WR, Vargas S, Larsen M, Elemans CP, Canfield DE, Wörheide G. The last common ancestor of animals lacked the HIF pathway and respired in low-oxygen environments. Elife. 2018;7:e31176.

Article  PubMed  PubMed Central  Google Scholar 

Wang GL. Semenza GL Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem. 1993;268:21513–8.

Article  PubMed  CAS  Google Scholar 

Semenza GL, Nejfelt MK, Chi SM. Antonarakis SE Hypoxia-inducible nuclear factors bind to an enhancer element located 3’ to the human erythropoietin gene. Proc Natl Acad Sci U S A. 1991;88:5680–4.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Semenza GL, Koury ST, Nejfelt MK, Gearhart JD. Antonarakis SE Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci U S A. 1991;88:8725–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292:464–8.

Article  PubMed  CAS  Google Scholar 

Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468–72.

Article  PubMed  CAS  Google Scholar 

Lee CC, Wu CY, Yang HY. Discoveries of how cells sense oxygen win the 2019 Nobel Prize in Physiology or medicine. Biomed J. 2020;43:434–7.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Hayashi Y, Yokota A, Xu Z, Zhang Y, Huang R, et al. Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models. Haematologica. 2018;103:40–50.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

Article  PubMed  CAS  Google Scholar 

Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31–46.

Article  PubMed  CAS  Google Scholar 

Downes NL, Laham-Karam N, Kaikkonen MU, Ylä-Herttuala S. Differential but complementary HIF1α and HIF2α transcriptional regulation. Mol Ther. 2018;26:1735–45.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tan C, de Noronha RG, Roecker AJ, Pyrzynska B, Khwaja F, Zhang Z, et al. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res. 2005;65:605–12.

Article  PubMed  CAS  Google Scholar 

Martin F, Linden T, Katschinski DM, Oehme F, Flamme I, Mukhopadhyay CK, et al. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood. 2005;105:4613–9.

Article  PubMed  CAS  Google Scholar 

Sharma A, Sinha S, Shrivastava N. Therapeutic targeting hypoxia-inducible factor (HIF-1) in cancer: cutting gordian knot of cancer cell metabolism. Front Genet. 2022;13:849040.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ma Z, Xiang X, Li S, Xie P, Gong Q, Goh BC, Wang L. Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds. Semin Cancer Biol. 2022;80:379–90.

Article  PubMed  CAS  Google Scholar 

Semenza GL. Pharmacologic targeting of hypoxia-inducible factors. Annu Rev Pharmacol Toxicol. 2019;59:379–403.

Article  PubMed  CAS  Google Scholar 

Wu D, Potluri N, Lu J, Kim Y, Rastinejad F. Structural integration in hypoxia-inducible factors. Nature. 2015;524:303–8.

Article  PubMed  CAS  Google Scholar 

Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol. 2014;76:39–56.

Article  PubMed  CAS  Google Scholar 

Figarella K, Kim J, Ruan W, Mills T, Eltzschig HK, Yuan X. Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome. Front Immunol. 2024;15:1328565.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, et al. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem. 2004;279:38458–65.

Article